Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Implantable defibrillators versus medical therapy for cardiac channelopathies.

McNamara DA, Goldberger JJ, Berendsen MA, Huffman MD.

Cochrane Database Syst Rev. 2015 Oct 7;(10):CD011168. doi: 10.1002/14651858.CD011168.pub2. Review.

PMID:
26445202
2.

Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications.

Olde Nordkamp LR, Postema PG, Knops RE, van Dijk N, Limpens J, Wilde AA, de Groot JR.

Heart Rhythm. 2016 Feb;13(2):443-54. doi: 10.1016/j.hrthm.2015.09.010. Epub 2015 Sep 15. Review.

PMID:
26385533
3.

Physical and Psychological Consequences of Left Cardiac Sympathetic Denervation in Long-QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia.

Waddell-Smith KE, Ertresvaag KN, Li J, Chaudhuri K, Crawford JR, Hamill JK, Haydock D, Skinner JR; Cardiac Inherited Disease Group New Zealand.

Circ Arrhythm Electrophysiol. 2015 Oct;8(5):1151-8. doi: 10.1161/CIRCEP.115.003159. Epub 2015 Jul 29.

4.

Utility of the exercise electrocardiogram testing in sudden cardiac death risk stratification.

Refaat MM, Hotait M, Tseng ZH.

Ann Noninvasive Electrocardiol. 2014 Jul;19(4):311-8. doi: 10.1111/anec.12191. Review.

PMID:
25040480
5.

New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia.

Jabbari J, Jabbari R, Nielsen MW, Holst AG, Nielsen JB, Haunsø S, Tfelt-Hansen J, Svendsen JH, Olesen MS.

Circ Cardiovasc Genet. 2013 Oct;6(5):481-9. doi: 10.1161/CIRCGENETICS.113.000118. Epub 2013 Sep 11.

6.

Electrical storm in children.

Clausen H, Pflaumer A, Kamberi S, Davis A.

Pacing Clin Electrophysiol. 2013 Mar;36(3):391-401. doi: 10.1111/pace.12050. Epub 2012 Dec 18. Review.

PMID:
23252797
7.

Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments.

van der Werf C, Zwinderman AH, Wilde AA.

Europace. 2012 Feb;14(2):175-83. doi: 10.1093/europace/eur277. Epub 2011 Sep 4. Review. Erratum in: Europace. 2012 Dec;14(12):1810.

PMID:
21893508
8.

Heart Rhythm UK position statement on clinical indications for implantable cardioverter defibrillators in adult patients with familial sudden cardiac death syndromes.

Garratt CJ, Elliott P, Behr E, Camm AJ, Cowan C, Cruickshank S, Grace A, Griffith MJ, Jolly A, Lambiase P, McKeown P, O'Callagan P, Stuart G, Watkins H; Heart Rhythm UK Familial Sudden Cardiac Death Syndromes Statement Development Group.

Europace. 2010 Aug;12(8):1156-75. doi: 10.1093/europace/euq261.

PMID:
20663787
9.

State of postmortem genetic testing known as the cardiac channel molecular autopsy in the forensic evaluation of unexplained sudden cardiac death in the young.

Ackerman MJ.

Pacing Clin Electrophysiol. 2009 Jul;32 Suppl 2:S86-9. doi: 10.1111/j.1540-8159.2009.02393.x. Review.

10.

Abnormal ryanodine receptor function in heart failure.

Yano M, Yamamoto T, Ikemoto N, Matsuzaki M.

Pharmacol Ther. 2005 Sep;107(3):377-91. Review.

PMID:
15951021

Supplemental Content

Loading ...
Support Center